Literature DB >> 2536411

Immunologic specificity of isocyanate-induced IgE antibodies in serum from 10 sensitized workers.

U Wass1, L Belin.   

Abstract

A procedure for the preparation of RAST disks used to assay isocyanate-specific IgE antibodies was developed. The outcome of the RAST was found to be strongly dependent on how the isocyanate test antigen was synthesized. Specific IgE from selected workers with isocyanate asthma reacted optimally to conjugates with less than or equal to 10 isocyanate molecules bound per molecule of human serum albumin. Further haptenization resulted in decreased specific binding and increased nonspecific binding because of high levels of total IgE. The hapten and carrier specificity of isocyanate-induced IgE antibodies were studied by direct RAST and RAST inhibition. The existence of new antigenic determinants related to both the isocyanate hapten and the carrier could be demonstrated. It was important to use a test antigen prepared from the same isocyanate as that to which the worker had been exposed, since the cross-reactivity between different isocyanate haptens was partial and varied from one patient to another. It was confirmed that isocyanate-specific IgE antibodies can be demonstrated only in a subgroup of workers with isocyanate-related bronchial asthma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536411     DOI: 10.1016/0091-6749(89)90487-9

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  17 in total

Review 1.  Developments in laboratory diagnostics for isocyanate asthma.

Authors:  Adam V Wisnewski
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-04

2.  Toluene diisocyanate reactivity with glutathione across a vapor/liquid interface and subsequent transcarbamoylation of human albumin.

Authors:  Adam V Wisnewski; Justin M Hettick; Paul D Siegel
Journal:  Chem Res Toxicol       Date:  2011-08-10       Impact factor: 3.739

3.  Glutathione reaction products with a chemical allergen, methylene-diphenyl diisocyanate, stimulate alternative macrophage activation and eosinophilic airway inflammation.

Authors:  Adam V Wisnewski; Jian Liu; Christopher M Colangelo
Journal:  Chem Res Toxicol       Date:  2015-02-18       Impact factor: 3.739

4.  Molecular determinants of humoral immune specificity for the occupational allergen, methylene diphenyl diisocyanate.

Authors:  Adam V Wisnewski; Jian Liu
Journal:  Mol Immunol       Date:  2013-01-04       Impact factor: 4.407

5.  Vapor conjugation of toluene diisocyanate to specific lysines of human albumin.

Authors:  Justin M Hettick; Paul D Siegel; Brett J Green; Jian Liu; Adam V Wisnewski
Journal:  Anal Biochem       Date:  2011-12-13       Impact factor: 3.365

6.  Reaction products of hexamethylene diisocyanate vapors with "self" molecules in the airways of rabbits exposed via tracheostomy.

Authors:  Adam V Wisnewski; Jean Kanyo; Jennifer Asher; James A Goodrich; Grace Barnett; Lyn Patrylak; Jian Liu; Carrie A Redlich; Ala F Nassar
Journal:  Xenobiotica       Date:  2017-06-01       Impact factor: 1.908

7.  Occupational asthma and extrinsic alveolitis due to isocyanates: current status and perspectives.

Authors:  O Vandenplas; J L Malo; M Saetta; C E Mapp; L M Fabbri
Journal:  Br J Ind Med       Date:  1993-03

8.  Connecting glutathione with immune responses to occupational methylene diphenyl diisocyanate exposure.

Authors:  Adam V Wisnewski; Jian Liu; Carrie A Redlich
Journal:  Chem Biol Interact       Date:  2013-06-20       Impact factor: 5.192

9.  The influence of diisocyanate antigen preparation methodology on monoclonal and serum antibody recognition.

Authors:  Lauren M Hagerman; Brandon F Law; Toni A Bledsoe; Justin M Hettick; Michael L Kashon; Angela R Lemons; Adam V Wisnewski; Paul D Siegel
Journal:  J Occup Environ Hyg       Date:  2016-11       Impact factor: 2.155

10.  Human innate immune responses to hexamethylene diisocyanate (HDI) and HDI-albumin conjugates.

Authors:  A V Wisnewski; Q Liu; J Liu; C A Redlich
Journal:  Clin Exp Allergy       Date:  2008-06       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.